This stability is unusual among peptide research compounds and allows investigators to use BPC-157 in both oral and parenteral administration designs in pre-clinical models
B12 aids in: Reducing inflammation Supporting muscle repair Decreasing muscle soreness This can lead to shorter recovery periods between training sessions, allowing for more frequent and intense workouts
B12 lowers levels of a compound known as homocysteine which is linked to an increased risk of heart attacks and stroke
were the first to encounter CHAC1 expression in the context of cancer cell death ( CHAC1 gene is highly upregulated in HNSC cancer after treatment with nisin which was then followed by cell death ( CHAC1 gene even though basal CHAC1 expression is significantly lower than in normal tissues ( CHAC1 upregulation after exposing HT-1080 (fibrosarcoma cell line) and Calu-1 (non-small-cell lung cancer) cells to artesunate, whereas in more recent studies, a significant increase in CHAC1 expression in Burkitts lymphoma cells was observed (Wang et al., 2019)
Raffo writes that, These combined effects are particularly intriguing for orthopedics because many musculoskeletal injuries (Achilles tendon ruptures, rotator cuff tears, chronic tendinopathies) occur in precisely those areas where blood flow is limited and healing is frustratingly slow. However, to be clear, BPC-157 is not FDA approved